Impact Factor 6.429

The 5th most cited journal in Immunology

Correction ARTICLE

Front. Immunol., 08 March 2017 | https://doi.org/10.3389/fimmu.2017.00213

Corrigendum: Semaphorin 4C: A Novel Component of B-Cell Polarization in Th2-Driven Immune Responses

imageDi Xue1, imageMarylin Desjardins1,2, imageGabriel N. Kaufman1, imageMarianne Béland1, imageSalem Al-Tamemi2,3, imageEisha Ahmed1, imageShao Tao1, imageRoland H. Friedel4, imageWalid Mourad5 and imageBruce D. Mazer1,2*
  • 1Translational Research in Respiratory Diseases, The Research Institute of the McGill University Health Center, Montreal, QC, Canada
  • 2McGill University Health Center, Montreal Children’s Hospital, Montreal, QC, Canada
  • 3Sultan Qaboos University Hospital, Muscat, Oman
  • 4Icahn School of Medicine at Mount Sinai, New York, NY, USA
  • 5Department of Medicine, University de Montreal, Montreal, QC, Canada

A Corrigendum on

Semaphorin 4C: A Novel Component of B-Cell Polarization in Th2-Driven Immune Responses
by Xue D, Desjardins M, Kaufman GN, Béland M, Al-Tamemi S, Ahmed E, et al. Front Immunol (2016) 7:558. doi: 10.3389/fimmu.2016.00558

There was a mistake in the name of the author Salem Al-Tememi as published. The correct spelling of the name should be Salem Al-Tamemi. The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way.

In the original article, we neglected to thank Immunodeficiency Canada for providing grant support for part of the study via the Chaim Roifman Award Program. The correct Funding section is below.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding

The authors acknowledge the financial support of Natural Sciences and Engineering Research Council (NSERC) Grant 47480, the Canadian Institute for Health Research (CIHR) Grant MOP-142247, The Research Institute of the McGill University Health Center (RI-MUHC), Montreal Chest Institute, Costello Foundation, the Strauss Family Foundation and we thank the Immunodeficiency Canada for providing grant support for part of the study via the Chaim Roifman Award Program. BM was a Chercheur National of the Fonds de Recherche du Québec-Santé. MD was the recipient of a Strauss Fellowship from McGill University and the Allergen-NCE Clinician Scientist Award.

The authors apologize for this oversight. This error does not change the scientific conclusions of the article in any way.

The original article has been updated.

Keywords: semaphorin 4C, B-cells, immune synapse, Th2 responses

Citation: Xue D, Desjardins M, Kaufman GN, Béland M, Al-Tamemi S, Ahmed E, Tao S, Friedel RH, Mourad W and Mazer BD (2017) Corrigendum: Semaphorin 4C: A Novel Component of B-Cell Polarization in Th2-Driven Immune Responses. Front. Immunol. 8:213. doi: 10.3389/fimmu.2017.00213

Received: 25 January 2017; Accepted: 15 February 2017;
Published: 08 March 2017

Edited and Reviewed by: Barbara L. Kee, University of Chicago, USA

Copyright: © 2017 Xue, Desjardins, Kaufman, Béland, Al-Tamemi, Ahmed, Tao, Friedel, Mourad and Mazer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Bruce D. Mazer, bruce.mazer@mcgill.ca